Outset Medical, Inc. Financing Cash Flow
Outset Medical, Inc. (OM) reported Financing Cash Flow of $413.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Outset Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$88.00K.
- Outset Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $501.00K, a 99.10% decline year-over-year.
- Outset Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00.
- Outset Medical, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $231.00K, a 90.91% increase year-over-year.
- Outset Medical, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $55.50M, a 18.22% decline from fiscal 2024.
- Outset Medical, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $67.87M, a 55.48% increase from fiscal 2023.
- Outset Medical, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $43.65M, a 40.12% decline from fiscal 2022.
- Outset Medical, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $72.90M, a 54.48% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $413.00K 10-Q · filed 2026-08-06 | $413.00K derived: sum of 3 quarters · filed 2026-08-06 | $644.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $501.00K 10-Q · filed 2026-05-07 | $501.00K derived: sum of 2 quarters · filed 2026-05-07 | $732.00K derived: sum of 3 quarters · filed 2026-05-07 | $348.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $231.00K derived: sum of 2 quarters · filed 2026-02-13 | -$153.00K derived: sum of 3 quarters · filed 2026-08-06 | $55.50M 10-K · filed 2026-02-13 |
| 2025-09-30 | $231.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$153.00K derived: sum of 2 quarters · filed 2026-08-06 | $55.50M 10-Q · filed 2025-11-10 | $54.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$384.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $55.27M 10-Q · filed 2026-08-06 | $54.33M derived: sum of 3 quarters · filed 2026-08-06 | $54.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $55.66M 10-Q · filed 2026-05-07 | $54.72M derived: sum of 2 quarters · filed 2026-05-07 | $54.84M derived: sum of 3 quarters · filed 2026-05-07 | $54.92M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$938.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$817.00K derived: sum of 2 quarters · filed 2026-02-13 | -$740.00K derived: sum of 3 quarters · filed 2026-02-13 | $67.87M 10-K · filed 2026-02-13 |
| 2024-09-30 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $198.00K derived: sum of 2 quarters · filed 2025-11-10 | $68.81M 10-Q · filed 2025-11-10 | $102.04M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $68.69M 10-Q · filed 2025-08-07 | $101.92M derived: sum of 3 quarters · filed 2026-02-13 | $106.02M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $68.61M 10-Q · filed 2025-05-08 | $101.84M derived: sum of 2 quarters · filed 2026-02-13 | $105.94M derived: sum of 3 quarters · filed 2026-02-13 | $106.98M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $33.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $37.33M derived: sum of 2 quarters · filed 2026-02-13 | $38.38M derived: sum of 3 quarters · filed 2026-02-13 | $43.65M 10-K · filed 2026-02-13 |
| 2023-09-30 | $4.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $5.15M derived: sum of 2 quarters · filed 2024-11-07 | $10.42M 10-Q · filed 2024-11-07 | $76.02M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $6.32M 10-Q · filed 2024-08-08 | $71.92M derived: sum of 3 quarters · filed 2025-02-28 | $74.45M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $5.28M 10-Q · filed 2024-05-09 | $70.88M derived: sum of 2 quarters · filed 2025-02-28 | $73.41M derived: sum of 3 quarters · filed 2025-02-28 | $74.45M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $65.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $68.13M derived: sum of 2 quarters · filed 2025-02-28 | $69.17M derived: sum of 3 quarters · filed 2025-02-28 | $72.90M 10-K · filed 2025-02-28 |
| 2022-09-30 | $2.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.58M derived: sum of 2 quarters · filed 2023-11-08 | $7.30M 10-Q · filed 2023-11-08 | $8.23M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.76M 10-Q · filed 2023-08-03 | $5.70M derived: sum of 3 quarters · filed 2024-02-21 | $11.89M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $3.72M 10-Q · filed 2023-05-04 | $4.66M derived: sum of 2 quarters · filed 2024-02-21 | $10.84M derived: sum of 3 quarters · filed 2024-02-21 | $161.65M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $934.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $7.12M derived: sum of 2 quarters · filed 2024-02-21 | $157.93M derived: sum of 3 quarters · filed 2024-02-21 | $160.15M 10-K · filed 2024-02-21 |
| 2021-09-30 | $6.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $157.00M derived: sum of 2 quarters · filed 2022-11-09 | $159.21M 10-Q · filed 2022-11-09 | $158.34M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $150.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $153.03M 10-Q · filed 2022-08-02 | $152.15M derived: sum of 3 quarters · filed 2023-02-13 | $411.91M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $2.22M 10-Q · filed 2022-05-05 | $1.34M derived: sum of 2 quarters · filed 2023-02-13 | $261.10M derived: sum of 3 quarters · filed 2023-02-13 | $261.13M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | -$873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $258.88M derived: sum of 2 quarters · filed 2023-02-13 | $258.91M derived: sum of 3 quarters · filed 2023-02-13 | $385.68M 10-K · filed 2023-02-13 |
| 2020-09-30 | $259.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $259.79M derived: sum of 2 quarters · filed 2021-11-04 | $386.56M 10-Q · filed 2021-11-04 | $386.66M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $126.80M 10-Q · filed 2021-08-06 | $126.90M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2020-03-31 | $126.77M 10-Q · filed 2021-05-06 | $126.88M derived: sum of 2 quarters · filed 2022-02-23 | ||
| 2019-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $249.00K 10-K · filed 2022-02-23 | ||
| 2019-09-30 | $143.00K 10-Q · filed 2020-11-12 | |||
| 2018-12-31 | $134.87M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |